Suppr超能文献

新冠肺炎患者出院后的肝功能恢复情况:一项随访研究。

Liver function recovery of COVID-19 patients after discharge, a follow-up study.

机构信息

Central laboratory, Shenzhen Samii Medical Center, Shenzhen city, Guangdong province, China, 518118.

Neurology department, Shenzhen Samii Medical Center, Shenzhen city, Guangdong province, China, 518118.

出版信息

Int J Med Sci. 2021 Jan 1;18(1):176-186. doi: 10.7150/ijms.50691. eCollection 2021.

Abstract

The aim of this study was to observe the liver function recovery of COVID-19 patients after discharge. A total of 253 discharged COVID-19 patients in Shenzhen city, China were selected. The clinical characteristics of these patients were assessed. A 2-month follow-up and laboratory hematology test were performed to examine the status of patients' liver function. Patients combined with liver diseases, especially fatty liver, are more likely to progress to severe condition (0.05). Patients in severe condition and those with liver diseases have higher rates of liver injuries during hospitalization, characterized by a significant increase in alanine aminotransferase (ALT) and aspartate aminotransferase (AST, 0.01). The ALT, AST/ALT, gamma-glutamyl transferase (GGT), alkaline phosphatase (ALP), total protein (TP), albumin (ALB), and A/G levels showed significant differences in comparison with the control group (0.05, and 0.001); and the outlier ratio of A/G, ALT, GGT and ALP of patients remained abnormal higher within 14 days after discharge (0.001). Liver injuries of COVID-19 patients may be related to the epidemiological characteristics, clinical indexes, basic diseases, symptoms, drug treatment during hospitalization and the complications. Indicators of liver function were correlated with cardiac function, renal function, thyroid function, lipid metabolism, glucose metabolism, immune index, leukocyte, erythrocyte, hemoglobin and platelet related indexes. The outlier ratio of TP, ALB and GLB remained extremely low throughout the follow-up period; the outlier ratio of ALT, AST and GGT decreased below 10% from a high level at 40 days after discharged. However, the outlier ratio of A/G, AST/ALT and ALP remained high during the follow-up period. : Abnormal liver function might indicate worse recovery of COVID-19 patients. Changes in liver function should be emphasized during long-term follow-up of COVID-19 patients after hospital discharge; the necessity of employing appropriate interventions for liver function repair should be emphasized.

摘要

本研究旨在观察 COVID-19 患者出院后的肝功能恢复情况。选取中国深圳市 253 例出院 COVID-19 患者,评估其临床特征。进行 2 个月的随访和实验室血液学检查,以检查患者肝功能状况。合并肝脏疾病,特别是脂肪肝的患者更容易进展为重症(0.05)。住院期间重症患者和合并肝脏疾病的患者肝损伤发生率更高,表现为丙氨酸氨基转移酶(ALT)和天冬氨酸氨基转移酶(AST,0.01)显著升高。与对照组相比,ALT、AST/ALT、γ-谷氨酰转移酶(GGT)、碱性磷酸酶(ALP)、总蛋白(TP)、白蛋白(ALB)和 A/G 水平均有显著差异(0.05,和 0.001);出院后 14 天内,A/G、ALT、GGT 和 ALP 的离群比值仍保持异常偏高(0.001)。COVID-19 患者的肝功能损伤可能与流行病学特征、临床指标、基础疾病、症状、住院期间药物治疗以及并发症有关。肝功能指标与心功能、肾功能、甲状腺功能、脂代谢、糖代谢、免疫指标、白细胞、红细胞、血红蛋白和血小板相关指标相关。TP、ALB 和 GLB 的离群比值在整个随访期间均保持极低水平;出院后 40 天,ALT、AST 和 GGT 的离群比值从高水平下降至 10%以下。然而,A/G、AST/ALT 和 ALP 的离群比值在随访期间仍保持较高水平。结论:异常的肝功能可能表明 COVID-19 患者的恢复情况较差。在 COVID-19 患者出院后进行长期随访时,应强调对肝功能变化的监测;应强调对肝功能修复进行适当干预的必要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b50/7738966/65ce3fb0db95/ijmsv18p0176g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验